Current Initiatives
Sweden currently hosts a range of nationally supported initiatives advancing various aspects of ATMP (Advanced Therapy Medicinal Products) development. These projects involve key stakeholder groups and target different areas within the ATMP landscape.
You can find more information about each initiative, including relevant contacts, through the links below.
If you’re interested in exploring how your ATMP activities might align with the Swedish ATMP ecosystem, please don’t hesitate to get in touch.
Advanced bioproduction by continuous bioprocessing.
AI-based QC method of cells for ATMP manufacturing.
Nordic infrastructure for development, manufacture and commercialisation.
Digitalised AI tool for safe ATMPs
Tillgängliggöra Svensk ATMP forskningsinfrastruktur.
For safer, more efficacious and accessible AAV gene therapy.
Regional ATMP knowledge centers and contact points for Swedish healthcare.
Technology solutions for hPSC derived cell therapy manufacture.
Towards enabling industrial scale production of ATMPs
For novel, safe, affordable and curative cancer treatments.
Doctoral program in preclinical and clinical advanced therapies.
Säkerställa hållbar forskning, translation, behandling och Regionala samverkan
Increasing access to high quality, commercially relevant iPSC start material
Network for clinical implementation and followup of CAR T medicines.
A better place to test your research
An expert function in cell therapy and ATMP activities